Open Access

Cardiogenic shock in a patient with hypothyroid myopathy responsive only to thyroxin replacement: a case report

  • Sanath Dharmasena1Email author,
  • Olga Burzyantseva1,
  • Suriya Jayawardana2,
  • Vijay A Rupanagudy3 and
  • Krishnan Pathmanathan3
Cases Journal20103:66

DOI: 10.1186/1757-1626-3-66

Received: 18 September 2009

Accepted: 23 February 2010

Published: 23 February 2010

Abstract

The effect of hypothyroidism on the cardiovascular system has been well documented. Cardiac dysfunction due to hypothyroidism manifests as both systolic and diastolic dysfunction of the heart leading to cardiac arrhythmia and congestive heart failure. Its presentation in the form of refractory hypotension is rare. We describe a 52 year old man on whom Hypothyroid Cardiomyopathy manifested as cardiogenic shock responsive only to thyroxin replacement.

Case presentation

A 52 year old man with nausea and vomiting of two days duration was found to be hypotensive and in acute hypoxic respiratory failure requiring mechanical ventilation. The patient is known to have hypothyroidism and he has been non compliant with oral Synthroid therapy. Hypotension persisted in spite of aggressive initial fluid resuscitation. The electrolytes, renal function, white blood count and hemoglobin were all within normal limits. Blood TSH level was 69.45 mU/L (0.35-5.50 mU/L); T4 level was 0.454 ng/dl (0.93-1.7 ng/dL) and T3 level was 29.87 ng/dl (84-202 ng/dL) all indicative of severe primary hypothyroidism. The Chest x-ray revealed normal heart size with pulmonary congestion. The EKG revealed a heart rate of 96/min with normal axis and rhythm and without ischemic changes. Patient remained hypotensive in spite of initiation of dopamine infusion. A bed side echocardiography revealed a left ventricular ejection fraction (LVEF) of 30% with global hypokinesia. The isovolumetric contraction time and isovolumetric relaxation time were prolonged with increased myocardial performance index (MPI) of (0.56) indicating that there was both systolic and diastolic dysfunction. An echocardiogram done six month ago showed a normal LVEF and normal MPI.

Hypotension persisted in spite of high dose dopamine infusion. In the absence of evidence of myocardial ischemia hypothyroidism was considered to be responsible for the observed acute refractory hypotension/cardiogenic shock. Intravenous thyroxin at a dose of 0.050 mg was administered and the dose increased to 0.075 mg in the next 48 hours resulting in stabilization of the blood pressure and weaning off the dopamine and subsequently weaned off ventilator during the next 72 hours. A repeat echocardiography done in one month revealed normal LV function with LVEF of 60% with normal MPI of 0.35.

Discussion

The effects of thyroid hormone on cardiac function are well documented [1]. Thyroid hormone has widespread effects on cardiovascular function [2]. Triiodothyronine, the active form of thyroid hormone, enters cardiomyocyte nuclei and modulates calcium flux, beta-adrenergic-receptor function, and the transcription of various contractile proteins. Both hyper and hypothyroidism can cause changes in cardiac contraction, In addition, severe hypothyroidism is associated with ventricular dysrhythmias, including torsades de pointes [3]. Hypothyroidism is associated with depressed chronotropy, increased peripheral vascular resistance, decreased cardiac contractility and decreased cardiac output and these effects are reversed with counteracting the hypothyroid state [46]. While cardiac dysfunction is well documented secondary to hypothyroidism, hypotension is rare and when it occurs it is resistant to conventional therapy in the form of intravenous fluids and vasopressors [7]. Hypothyroidism causes muscle relaxation and the isovolumetric relaxation and contraction time becomes prolonged and MPI increases indicating systolic and diastolic dysfunction [8]. Only when Cardiac dysfunction is severe, cardiac out put can be decreased enough to cause cardiogenic shock. In such situations urgent thyroxin replacement has been shown to improve cardiac function and restore hemodynamic stability [9, 10] as was the case in the patient we described.

Conclusion

Hypothyroid cardiomyopathy can manifest as cardiogenic shock and only thyroxin replacement can restore hemodynamic stability by reversing the systolic and diastolic dysfunction.

Consent

A written informed consent was obtained from the patient for publication of this case report. A copy of the written consent will be made available on request.

List of Abbreviations

(LVEF): 

left ventricular ejection fraction

(MPI): 

myocardial performance index.

Declarations

Acknowledgements

The above case report was written at Coney Island Hospital. The above mentioned authors have no affiliation to any other institute other than Coney Island Hospital.

Authors’ Affiliations

(1)
Department of Medicine, Coney Island Hospital
(2)
Department of Cardiology, Coney Island Hospital
(3)
Department of Pulmonology, Coney Island Hospital

References

  1. Danzi S, Klein I: Thyroid hormone and the cardiovascular system. Minerva Endocrinol. 2004, 29 (3): 139-50.PubMedGoogle Scholar
  2. Ladenson PW, Sherman SI, Baughman KL, Ray PE, Feldman AM: Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA. 1992, 89 (12): 5251-5. 10.1073/pnas.89.12.5251.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Klein I, Danzi S: Thyroid disease and the heart. Circulation. 2007, 116 (15): 1725-35. 10.1161/CIRCULATIONAHA.106.678326.View ArticlePubMedGoogle Scholar
  4. Kahaly GJ, Dillmann WH: Thyroid hormone action in the heart. Endocr Rev. 2005, 26 (5): 704-28. 10.1210/er.2003-0033.View ArticlePubMedGoogle Scholar
  5. Zipes D, Libby P, Bonow R, Braunwald E: Endocrine disorders and cardiovascular disease. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Edited by: Zipes DP, Libby P, Bonow RO, Braunwald E. 2005, New York: Saunders, 2051-65. 7Google Scholar
  6. Palmieri EA, Fazio S, Lombardi G, Biondi B: Subclinical hypothyroidism and cardiovascular risk: a reason to treat?. Treat Endocrinol. 2004, 3 (4): 233-44. 10.2165/00024677-200403040-00005.View ArticlePubMedGoogle Scholar
  7. Ashwath ML, Kang G, Cunningham M, Adler DS: Cardiogenic shock in hypothyroidism. South Med J. 2006, 99 (5): 515-7. 10.1097/01.smj.0000215857.47925.fc.View ArticlePubMedGoogle Scholar
  8. Gordon H, Leonard S, WS E: The heart in endocrine and nutritional disorders. Heart disease a textbook of cardiovascular medicine. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Edited by: Zipes DP, Libby P, Bonow RO, Braunwald E. 1997, New York: Saunders, 1885-913. 5Google Scholar
  9. LeMar HJ, West SG, Garrett CR, Hofeldt FD: Covert hypothyroidism presenting as a cardiovascular event. Am J Med. 1991, 91 (5): 549-52. 10.1016/0002-9343(91)90194-3.View ArticlePubMedGoogle Scholar
  10. Ladenson PW, Goldenheim PD, Cooper DS, Miller MA, Ridgway EC: Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism. Am J Med. 1982, 73 (4): 467-74. 10.1016/0002-9343(82)90323-0.View ArticlePubMedGoogle Scholar

Copyright

© Dharmasena et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement